Sylvia Benzaken

Nice, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications

Artificial intelligence to guide rituximab therapy in patients with phospholipase A2 receptor-associated membranous nephropathy.

Artificial intelligence to guide rituximab therapy in patients with phospholipase A2 receptor-associated membranous nephropathy.

Journal: Clinical kidney journal
Published: November 16, 2024

Obinutuzumab and Ofatumumab are More Effective Than Rituximab in the Treatment of Membranous Nephropathy Patients With Anti-Rituximab Antibodies.

Obinutuzumab and Ofatumumab are More Effective Than Rituximab in the Treatment of Membranous Nephropathy Patients With Anti-Rituximab Antibodies.

Journal: Kidney international reports
Published: October 02, 2024

Optimization of Rituximab Therapy in Adult Patients With PLA2R1-Associated Membranous Nephropathy With Artificial Intelligence.

Optimization of Rituximab Therapy in Adult Patients With PLA2R1-Associated Membranous Nephropathy With Artificial Intelligence.

Journal: Kidney international reports
Published: June 29, 2023

Both Humoral and Cellular Immune Responses to SARS-CoV-2 Are Essential to Prevent Infection: a Prospective Study in a Working Vaccinated Population from Southern France.

Both Humoral and Cellular Immune Responses to SARS-CoV-2 Are Essential to Prevent Infection: a Prospective Study in a Working Vaccinated Population from Southern France.

Journal: Journal of clinical immunology
Published: January 20, 2023

Risk Factors Associated with the Occurrence of Anti-rituximab Antibodies in Membranous Nephropathy.

Risk Factors Associated with the Occurrence of Anti-rituximab Antibodies in Membranous Nephropathy.

Journal: Clinical journal of the American Society of Nephrology : CJASN
Published: November 04, 2022

Humoral and cellular responses after a third dose of SARS-CoV-2 mRNA vaccine in patients with glomerular disease.

Humoral and cellular responses after a third dose of SARS-CoV-2 mRNA vaccine in patients with glomerular disease.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: July 19, 2022

Low baseline IFN-γ response could predict hospitalization in COVID-19 patients.

Low baseline IFN-γ response could predict hospitalization in COVID-19 patients.

Journal: Frontiers in immunology
Published: May 26, 2022

Air pollution exposure induces a decrease in type II interferon response: A paired cohort study.

Air pollution exposure induces a decrease in type II interferon response: A paired cohort study.

Journal: EBioMedicine
Published: May 10, 2022

Toxic Occupational Exposures and Membranous Nephropathy.

Toxic Occupational Exposures and Membranous Nephropathy.

Journal: Clinical journal of the American Society of Nephrology : CJASN
Published: March 09, 2022

Humoral and cellular responses after a third dose of SARS-CoV-2 BNT162b2 vaccine in patients with lymphoid malignancies.

Humoral and cellular responses after a third dose of SARS-CoV-2 BNT162b2 vaccine in patients with lymphoid malignancies.

Journal: Nature communications
Published: September 13, 2021

Rituximab Immunomonitoring Predicts Remission in Membranous Nephropathy.

Rituximab Immunomonitoring Predicts Remission in Membranous Nephropathy.

Journal: Frontiers in immunology
Published: July 09, 2021

Humoral and Cellular Response of Frontline Health Care Workers Infected by SARS-CoV-2 in Nice, France: A Prospective Single-Center Cohort Study.

Humoral and Cellular Response of Frontline Health Care Workers Infected by SARS-CoV-2 in Nice, France: A Prospective Single-Center Cohort Study.

Journal: Frontiers in medicine
Published: September 21, 2020
Showing 1-12 of 25

Last Updated: 09/26/2026